About Male Infertility
Infertility is a widespread problem. In male infertility, the male fails to impregnate his female partner after a year of unprotected sex. Male infertility is due to a couple of factors including:
• Low sperm production
• Abnormal sperm function or
• Blockages that prevent the delivery of sperm.
Hormonal disturbances to physical problems, or psychological problems can cause male infertility. In most cases, there are no obvious sign or symptoms of an infertility problem. 20 percent of the total infertility is due to male factors. Despite of the scarcity of medicines to treat male infertility, many successful treatment options exist for its many causes.
The Global Male Infertility market to grow at a CAGR of 6.60 percent over the period 2014-2019.
Read more details at: http://www.bigmarketresearch.com/global-male-infertility-2015-2019-market
Covered in this Report
The Global Male Infertility market can be divided into seven segments: DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Penetration Assay, Sperm Agglutination, CASA, and Others. This report covers the present scenario and the growth prospects of the Global Male Infertility market for the period 2014–2019. To calculate the market size, the report considers the revenue generated from the sales of various diagnostic tests and equipment's used in the treatment of male infertility that are available in the market.
The Global Male Infertility Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Male Infertility market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• CooperSurgical Inc
• Elelixis Diagnostics SA
• Halotech DNA SL...